Windtree Therapeutics ( ($WINT) ) has released a notification of late filing. Windtree Therapeutics, Inc. has announced a delay in the filing of ...

Windtree Therapeutics, Inc. (NASDAQ: WINT), a healthcare company based in Warrington, Pennsylvania, has decided to execute a significant strategic pivot. The company announced on July 16 that it has ...

Windtree Therapeutics WINT just announced new preclinical data on the company’s lead product candidate, istaroxime, and another preclinical pipeline drug candidate, CVie-216, showing reductions ...

Windtree Therapeutics Inc (NASDAQ:WINT) shares have trended lower over the past two trading sessions following a strong surge in shares on Tuesday. Here's a look at what's going on.

Windtree Therapeutics, a Nasdaq listed biotechnology company, has plans to raise up to $200 million to build a treasury of BNB, the native cryptocurrency of BNB Chain. Warrington, Pennsylvia-based ...

WARRINGTON, Pa., Nov. 27, 2024 (GLOBE NEWSWIRE) -- Windtree Therapeutics (WINT), Inc. , a biotechnology company focused on advancing early and late-stage innovative therapies for critical ...

Windtree Therapeutics Appoints Jed Latkin as New CEO Windtree Therapeutics announces CEO Fraser to retire, Latkin to succeed Windtree Therapeutics Inc (WINT) Q3 Earnings Cheat Sheet ...

About Windtree Therapeutics, Inc. Windtree Therapeutics, Inc. is a biotechnology company focused on advancing early and late-stage innovative therapies for critical conditions and diseases.

Windtree Therapeutics Announces Closing of $30.0 Million Public Offering August 19, 2021 at 12:58 p.m.

WARRINGTON, Pa., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (WINT), a biotechnology company focused on advancing early and late-stage innovative therapies for critical ...

Windtree Therapeutics, Inc. has announced a new corporate strategy aimed at becoming a revenue-generating biotechnology firm through the acquisition of small companies with FDA-approved products ...